CN101411845B - Cancer-suppressing analgesic medicament - Google Patents
Cancer-suppressing analgesic medicament Download PDFInfo
- Publication number
- CN101411845B CN101411845B CN2007101897917A CN200710189791A CN101411845B CN 101411845 B CN101411845 B CN 101411845B CN 2007101897917 A CN2007101897917 A CN 2007101897917A CN 200710189791 A CN200710189791 A CN 200710189791A CN 101411845 B CN101411845 B CN 101411845B
- Authority
- CN
- China
- Prior art keywords
- restrains
- portions
- pain
- cancer
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for suppressing tumor and relieving pain, which is prepared from raw materials in the follow weight portion: 2 to 5 portions of toad, 20 to 30 portions of raw angelica dahurica, 20 to 30 portions of curcuma, 10 to 20 portions of raw southern star, 10 to 20 portions of unprocessed radix aconiti, 10 to 20 portions of processed strychnos, 3 to 10 portions of camphor, and 3 to 10 portions of borneol. The drug uses the toad and the curcuma to promote blood circulation and remove blood stasis, search wind and dispel filth, as well as remove obstruction meridian and relieve pain, uses the processed strychnos and the raw southern star to disperse abscess and nodule, and relieve pain and resist tumor, uses the unprocessed radix aconite and the raw angelica dahurica to expel wind and remove dampness, as well as disperse abscess and relieve pain, and uses the borneol and the camphor as medicinal guides for dispelling filth with aroma, and opening orifices and inducing resuscitation. All the medicines are used together to achieve the effects of softening hardness to dissipate stagnation, dispersing abscess and relieving pain, combating poison with poison, and suppressing cancer and stopping pain. Through clinical applications, the pain relieving rate reaches 75 percent, the cancer suppressing rate reaches 66 percent, while the proportion of the side effect is only 13 percent, so the drug has dual functions of relieving pain and suppressing cancer with smaller side effects.
Description
Technical field
The invention belongs to medicine, relate in particular to a kind of cancer analgesic drug product that presses down.
Background technology
It is the most painful thing of patient that advanced tumor has an intense pain, Western medicine all adopts the narcoticness analgesia such as morphine, dolantin, tramadol hydrochloride etc. now, but narcoticness analgesia use all day exist pain relieving and do not press down cancer, side effect is big and the drawback of addiction, giddy, perspiration, xerostomia can occur, feel sick, symptom such as tachycardia.
Summary of the invention
The objective of the invention is to overcome existing Western medicine pain relieving but the big deficiency of side effect, provide a kind of and have pain relieving, press down cancer dual function and side effect very little press down the cancer analgesic drug product.
For achieving the above object, the present invention adopts following technical scheme: a kind of cancer analgesic drug product that presses down is formed by the feedstock production of following weight parts: Bufo siccus 2～5, give birth to the Radix Angelicae Dahuricae 20～30, Rhizoma Curcumae Longae 20～30, Rhizoma Arisaematis 10～20, Radix Aconiti 10～20, Semen Strychni (processed) 10～20, Camphora 3～10, Borneolum Syntheticum 3～10.
The described cancer analgesic drug product that presses down is formed by the feedstock production of following weight parts: Bufo siccus 2, give birth to the Radix Angelicae Dahuricae 28, Rhizoma Curcumae Longae 22, Rhizoma Arisaematis 14, Radix Aconiti 14, Semen Strychni (processed) 14, Camphora 3, Borneolum Syntheticum 3.
The described preparation method that presses down the cancer analgesic drug product: Bufo siccus, the living Radix Angelicae Dahuricae, Rhizoma Curcumae Longae, Rhizoma Arisaematis, Radix Aconiti and Semen Strychni (processed) are made powder, mix homogeneously; Take by weighing vaseline, vaseline is placed on container is built in the fusing of heating in the hot water, aforesaid powder is slowly added stirring extractum, go that temperature camphorates after cooling, Borneolum Syntheticum, restir evenly gets final product, and the weight of vaseline is 90% of all crude drug weight.
In the present invention the nature and flavor of the crude drug of Cai Yonging, return through and function as follows:
Bufo siccus: hot, cool, poisonous, GUIXIN, liver, lung, spleen channel, detoxicating and resolving stagnation of pathogens, parasite killing, analgesic therapy.
The Radix Angelicae Dahuricae: suffering, temperature is gone into lung, stomach warp, expelling wind and removing dampness, the evacuation of pus of invigorating blood circulation, granulation promoting pain relieving.
Rhizoma Curcumae Longae: hot, bitter, temperature is returned spleen, Liver Channel, removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia.
Rhizoma Arisaematis: bitter, hot, temperature, poisonous, go into lung, liver, spleen channel, drying dampness to eliminate phlegm, expelling wind for relieving convulsion, dispersing swelling and dissipating binds.
Radix Aconiti: hot, bitter, heat, very toxic, go into the heart, liver, spleen channel, antalgic, expelling wind and cold.
Semen Strychni (processed): hardship, temperature, very toxic, return liver, spleen channel, mass dissipating and swelling eliminating, removing obstruction in the collateral to relieve pain.
Camphora: suffering, heat is gone into the heart, spleen channel, sensible dirty, warming middle-JIAO to relieve pain, the dampness removing parasite killing warded off.
Borneolum Syntheticum: hot, bitter, be slightly cold, go into the heart, spleen, lung meridian, analepsia is had one's ideas straightened out, clearing away heat to alleviate pain.
The present invention with Bufo siccus, Rhizoma Curcumae Longae blood circulation promoting and blood stasis dispelling, search wind and ward off dirty, inducing menstruation to relieve menalgia, press down tumor with Semen Strychni (processed), Rhizoma Arisaematis dispersing swelling and dissipating binds, pain relieving, with Radix Aconiti, living Radix Angelicae Dahuricae expelling wind and removing dampness, the hot pain relieving of loosing of detumescence, with Borneolum Syntheticum, Camphora fragrance walk to scurry, the refreshment of having one's ideas straightened out is priming, all medicines cooperates and reaches hard masses softening and resolving, reducing swelling and alleviating pain, treating the poisonous disease with poisonous drugs, presses down the painful surely effect of cancer.
The present invention only needs ointment is applied on the cloth in use, and the medicine layer thickness is 2 millimeters, directly sticks in the affected part to get final product, and applies at every turn and changes dressings after 3～5 days.In recent years, the inventor uses clinical drug of the present invention treatment patient 60 examples, male's 25 examples wherein, and women's 35 examples, the age, following table was to use the present invention and the Comparison of therapeutic of using Western medicine between 35～85 years old:
| Total number of persons | Pain relieving | Press down cancer | Side effect | |
| The present invention | 60 | 45 | 40 | 8 |
| Matched group | 60 | 54 | 3 | 55 |
As can be seen from the table, use pain relieving rate of the present invention to be lower than the use Western medicine slightly, but also reach 75%, and have the ratio of side effect to have only 13%, far below using Western medicine, cancer suppressing ratio reaches 66%, is higher than the cancer suppressing ratio that uses Western medicine far away.This shows, the present invention has pain relieving, press down the cancer dual function and side effect very little.
Below be several treatment cases:
Case 1: Yu Sirong, the man, nineteen fifty-two gives birth to, the patient suffers from lung tumor late period in calendar year 2001, pain is used earlier to ache by force and is decided unbearably, owing to produce drug resistance and effective drug duration weak point, use tramadol hydrochloride instead, owing to anti-ly can't stand side effect, just adopt ointment of the present invention local application, analgesic effect is remarkable, without any side effect, adhere to that medication is dead after life prolongs a year and a half.
Case 2: Liu Yongfeng, the man, nineteen sixty gives birth to, and the patient suffered from liver tumor late period in 2005, because pain is used benzoxazocine unbearably, the xerostomia symptom occurs, and analgesic time is short, uses ointment of the present invention instead, analgesic effect is satisfied, do not see any side effect, adhere to using continuity dead after 1 year, relieve the pain apparently higher than Western medicine anesthesia life cycle.
Case 3: Zheng Cheng Shi, the woman, nineteen twenty-three gives birth to, 85 years old now, suffer from esophageal carcinoma mid-term 1996 patient's years, through radiotherapy and Chinese medicine anticancer therapy, cancer cell metastasis appears again behind the life continuation to two year, and find as CT and invade the T12 joint, pain gets whole night and moans ceaselessly, action is by crutches, used ache by force decide, Western medicine such as codeine, analgesic effect is not good.Used the present invention afterwards, and progressively alleviated through three months treatment back pain, and changed into singly by crutches and turning, oneself can independent ambulation after eight months.Skin is itched a little outward once in a while, does not have other side effect, adheres to medication after 1 year, and health is good so far.
The specific embodiment
Embodiment 1: Bufo siccus, the living Radix Angelicae Dahuricae, Rhizoma Curcumae Longae, Rhizoma Arisaematis, Radix Aconiti and Semen Strychni (processed) are made powder, take by weighing Bufo siccus 2 gram respectively, give birth to the Radix Angelicae Dahuricae 28 grams, Rhizoma Curcumae Longae 22 grams, Rhizoma Arisaematis 14 grams, Radix Aconiti 14 grams, Semen Strychni (processed) 14 grams, mix homogeneously, take by weighing 90 gram vaseline again, vaseline is placed on container is built in the fusing of heating in the hot water, the medicated powder that takes by weighing is slowly added stirring extractum, remove temperature camphorate after cooling 3 grams, Borneolum Syntheticum 3 gram, restir evenly gets final product.
Embodiment 2: in the present embodiment, use Bufo siccus 2 restrains, the living Radix Angelicae Dahuricae 20 restrains, Rhizoma Curcumae Longae 20 restrains, Rhizoma Arisaematis 10 restrains, Radix Aconiti 10 restrains, Semen Strychni (processed) 10 restrains, Camphora 3 restrains, Borneolum Syntheticum 3 restrains and vaseline 70.2 restrains, and other is identical with embodiment 1.
Embodiment 3: in the present embodiment, use Bufo siccus 5 restrains, the living Radix Angelicae Dahuricae 30 restrains, Rhizoma Curcumae Longae 30 restrains, Rhizoma Arisaematis 20 restrains, Radix Aconiti 20 restrains, Semen Strychni (processed) 20 restrains, Camphora 10 restrains, Borneolum Syntheticum 10 restrains and vaseline 130.5 restrains, and other is identical with embodiment 1.
Embodiment 4: in the present embodiment, use Bufo siccus 5 restrains, the living Radix Angelicae Dahuricae 25 restrains, Rhizoma Curcumae Longae 25 restrains, Rhizoma Arisaematis 15 restrains, Radix Aconiti 15 restrains, Semen Strychni (processed) 15 restrains, Camphora 5 restrains, Borneolum Syntheticum 5 restrains and vaseline 99 restrains, and other is identical with embodiment 1.
Embodiment 5: in the present embodiment, use Bufo siccus 4 restrains, the living Radix Angelicae Dahuricae 21 restrains, Rhizoma Curcumae Longae 26 restrains, Rhizoma Arisaematis 18 restrains, Radix Aconiti 12 restrains, Semen Strychni (processed) 13 restrains, Camphora 8 restrains, Borneolum Syntheticum 6 restrains and vaseline 97.2 restrains, and other is identical with embodiment 1.
Embodiment 6: in the present embodiment, use Bufo siccus 3 restrains, the living Radix Angelicae Dahuricae 27 restrains, Rhizoma Curcumae Longae 25 restrains, Rhizoma Arisaematis 14 restrains, Radix Aconiti 17 restrains, Semen Strychni (processed) 11 restrains, Camphora 4 restrains, Borneolum Syntheticum 6 restrains and vaseline 96.3 restrains, and other is identical with embodiment 1.
Embodiment 7: in the present embodiment, use Bufo siccus 2 restrains, the living Radix Angelicae Dahuricae 29 restrains, Rhizoma Curcumae Longae 21 restrains, Rhizoma Arisaematis 17 restrains, Radix Aconiti 11 restrains, Semen Strychni (processed) 12 restrains, Camphora 6 restrains, Borneolum Syntheticum 4 restrains and vaseline 91.8 restrains, and other is identical with embodiment 1.
Embodiment 8: in the present embodiment, use Bufo siccus 3 restrains, the living Radix Angelicae Dahuricae 22 restrains, Rhizoma Curcumae Longae 23 restrains, Rhizoma Arisaematis 19 restrains, Radix Aconiti 13 restrains, Semen Strychni (processed) 18 restrains, Camphora 5 restrains, Borneolum Syntheticum 7 restrains and vaseline 99 restrains, and other is identical with embodiment 1.
Embodiment 9: in the present embodiment, use Bufo siccus 4 restrains, the living Radix Angelicae Dahuricae 26 restrains, Rhizoma Curcumae Longae 27 restrains, Rhizoma Arisaematis 11 restrains, Radix Aconiti 18 restrains, Semen Strychni (processed) 16 restrains, Camphora 7 restrains, Borneolum Syntheticum 9 restrains and vaseline 106.2 restrains, and other is identical with embodiment 1.
Embodiment 10: in the present embodiment, use Bufo siccus 3 restrains, the living Radix Angelicae Dahuricae 24 restrains, Rhizoma Curcumae Longae 29 restrains, Rhizoma Arisaematis 12 restrains, Radix Aconiti 19 restrains, Semen Strychni (processed) 11 restrains, Camphora 9 restrains, Borneolum Syntheticum 8 restrains and vaseline 103.5 restrains, and other is identical with embodiment 1.
Embodiment 9: in the present embodiment, use Bufo siccus 2 restrains, the living Radix Angelicae Dahuricae 27 restrains, Rhizoma Curcumae Longae 27 restrains, Rhizoma Arisaematis 14 restrains, Radix Aconiti 15 restrains, Semen Strychni (processed) 16 restrains, Camphora 5 restrains, Borneolum Syntheticum 3 restrains and vaseline 97.2 restrains, and other is identical with embodiment 1.
Embodiment 10: in the present embodiment, use Bufo siccus 5 restrains, the living Radix Angelicae Dahuricae 24 restrains, Rhizoma Curcumae Longae 24 restrains, Rhizoma Arisaematis 16 restrains, Radix Aconiti 14 restrains, Semen Strychni (processed) 15 restrains, Camphora 4 restrains, Borneolum Syntheticum 4 restrains and vaseline 95.4 restrains, and other is identical with embodiment 1.
Claims (3)
1. one kind is pressed down the cancer analgesic drug product, and it is characterized in that: active part is formed by the feedstock production of following weight parts: Bufo siccus 2～5, the living Radix Angelicae Dahuricae 20～30, Rhizoma Curcumae Longae 20～30, Rhizoma Arisaematis 10～20, Radix Aconiti 10～20, Semen Strychni (processed) 10～20, Camphora 3～10, Borneolum Syntheticum 3～10.
2. the cancer analgesic drug product that presses down as claimed in claim 1, it is characterized in that: active part is formed by the feedstock production of following weight parts: Bufo siccus 2, the living Radix Angelicae Dahuricae 28, Rhizoma Curcumae Longae 22, Rhizoma Arisaematis 14, Radix Aconiti 14, Semen Strychni (processed) 14, Camphora 3, Borneolum Syntheticum 3.
3. the preparation method that presses down the cancer analgesic drug product as claimed in claim 1 or 2 is characterized in that: Bufo siccus, the living Radix Angelicae Dahuricae, Rhizoma Curcumae Longae, Rhizoma Arisaematis, Radix Aconiti and Semen Strychni (processed) are made powder, mix homogeneously; Vaseline is placed on container is built in the fusing of heating in the hot water, aforesaid powder is slowly added stirring extractum, go that temperature camphorates after cooling, Borneolum Syntheticum, restir evenly gets final product, and the weight of vaseline is 90% of all crude drug weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101897917A CN101411845B (en) | 2007-10-19 | 2007-10-19 | Cancer-suppressing analgesic medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101897917A CN101411845B (en) | 2007-10-19 | 2007-10-19 | Cancer-suppressing analgesic medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101411845A CN101411845A (en) | 2009-04-22 |
| CN101411845B true CN101411845B (en) | 2011-09-14 |
Family
ID=40592723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101897917A Expired - Fee Related CN101411845B (en) | 2007-10-19 | 2007-10-19 | Cancer-suppressing analgesic medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101411845B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108904655A (en) * | 2018-08-28 | 2018-11-30 | 章尔丽 | A kind of instant reconciliation type plaster for treating tumour |
| CN111588805A (en) * | 2020-05-27 | 2020-08-28 | 袁希福 | Traditional Chinese medicine external-application paste for treating cancer bone metastasis pain and preparation method thereof |
-
2007
- 2007-10-19 CN CN2007101897917A patent/CN101411845B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101411845A (en) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN106943460A (en) | A kind of external preparation for being used to treat the proliferation of mammary gland | |
| CN101411845B (en) | Cancer-suppressing analgesic medicament | |
| CN104758844A (en) | Traditional Chinese medicine for treating premature ovarian failure | |
| CN102145101A (en) | Novel traditional Chinese medicine for treating rheumatic lumbocrural pains | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN104547825B (en) | A kind of preparation method for the Chinese medicine composition and its preparation for treating myoneural pain | |
| CN103933481B (en) | External used medicine of a kind for the treatment of of cancer pain and preparation method thereof | |
| CN103272195B (en) | Traditional Chinese medicine paste for treating pain | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN101647981B (en) | Drug for treating blood-deficiency and wind-dry type psoriasis | |
| CN103816381A (en) | Medicine for treating traumatic injuries and preparation method thereof | |
| CN103191306B (en) | Chinese medicinal external application medicament for treating thyroid nodules | |
| CN103157053A (en) | Pain-relieving traditional Chinese medicine preparation and preparation method thereof | |
| CN102895414B (en) | Chinese herbal paste for treating superficial cancer | |
| CN108524697A (en) | A kind of drug for treating prostatitis and hyperplasia | |
| CN105726849B (en) | It is a kind of for treating the Chinese medicine of diabetes Depression | |
| CN102626479B (en) | External-use Chinese herbal medicine composition for chronic rheumatism treatment | |
| CN107050302A (en) | Treat the external application Chinese medicine of burn and scald | |
| CN106860454A (en) | A kind of paste for reducing tazarotene Clinical practice side effect | |
| CN105267683A (en) | Chinese medical preparation for treating yin deficiency and poison type perianal and perirectal abscesses | |
| CN106074956A (en) | A kind of Chinese medicine composition for the treatment of CT enhanced ct scans contrast agent seepage | |
| CN116763882A (en) | Sanjiu plaster and preparation method and application thereof | |
| CN1404850A (en) | Anti-inflammatory pain-releaving and swelling-diminishing external-use medicine | |
| CN101011512A (en) | Medicine for treating digestive tract tumour and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20121019 |